Assessment of intensive statin therapy in hospitalized patients with acute myocardial infarction and its influence factors
10.3969/j.issn.1006-5725.2017.15.017
- VernacularTitle:2001-2011年急性心肌梗死住院患者强化他汀使用情况及其影响因素
- Author:
Huan QU
- Keywords:
acute myocardial infarction;
intensive statin therapy;
lipids
- From:
The Journal of Practical Medicine
2017;33(15):2492-2496
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the status quo of intensive statin therapy in hospitalized patients with acute myocardial infarction (AMI) from 2001 to 2011 and analyze its influence factors.Methods We obtained in-formation of AMI patients in 2001,2006,and 2011 from their medical record. Intensive statin therapy was defined as statin regiments with expected LDL-C lowering of at least 40%.Results Among 767 patientswith definite dosage of statin,the use frequencyof intensive statin increased from 0%in 2001 to 60.77% in 2006,and 88.71% in 2011 (P<0.0001).Morefemalesreceived intensive statin therapy than males(P=0.015)and the use frequency of intensive statin therapy in smoking patients was obviously more frequent than that in hypertension ,diabetes mellitus and hy-perlipidemia patients (P=0.0081).The use frequency of intensive statin therapy in patients with ischemic stroke was significantly lower than that in those with AMI or coronary artery disease(P=0.0437). AMI patients with STele-vatedwere much less likely received intensive statin therapy than those with non-ST elevated(P<0.0001). Chest pain,cardiac shock or cardiac arrest and the base level of LDL-C exerted no influence on the use of intensive statin therapy(P>0.05). Conclusions The use frequency of intensive stain therapy among AMI patientsincreasesyear by year and it is affected by sex,risk factors,history of disease and type of infarction.
